Higher IL‐18/IL‐18‐BP ratios were observed in tubular adenocarcinomas and PDACs compared to intestinal type adenocarcinomas, while no significant difference was observed between the other two groups. The gene discussed is IL18; the disease is gastric tubular adenocarcinoma.